Denka Company Limited

TSE:4061 Stock Report

Market Cap: JP¥176.6b

Denka Past Earnings Performance

Past criteria checks 3/6

Denka's earnings have been declining at an average annual rate of -19.7%, while the Chemicals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 1.5% per year. Denka's return on equity is 2.7%, and it has net margins of 2.2%.

Key information

-19.7%

Earnings growth rate

-19.6%

EPS growth rate

Chemicals Industry Growth6.6%
Revenue growth rate1.5%
Return on equity2.7%
Net Margin2.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)

May 21
Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)

Recent updates

Fewer Investors Than Expected Jumping On Denka Company Limited (TSE:4061)

Nov 08
Fewer Investors Than Expected Jumping On Denka Company Limited (TSE:4061)

Calculating The Intrinsic Value Of Denka Company Limited (TSE:4061)

Aug 20
Calculating The Intrinsic Value Of Denka Company Limited (TSE:4061)

Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)

May 21
Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)

Here's Why Denka (TSE:4061) Is Weighed Down By Its Debt Load

Mar 06
Here's Why Denka (TSE:4061) Is Weighed Down By Its Debt Load

Revenue & Expenses Breakdown

How Denka makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:4061 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24396,9488,76057,18812,680
30 Jun 24396,66111,90256,92312,680
31 Mar 24389,26311,94756,44412,680
31 Dec 23391,6697,50854,79812,680
30 Sep 23396,0005,00055,56712,680
30 Jun 23401,01910,72656,15912,680
31 Mar 23407,55912,76857,33712,680
31 Dec 22409,60511,94357,72511,947
30 Sep 22396,63422,29457,27311,947
30 Jun 22392,49124,19356,62511,947
31 Mar 22384,84926,01255,10411,947
31 Dec 21376,38326,80654,76312,501
30 Sep 21385,23230,82254,41412,501
30 Jun 21364,88524,75153,67312,501
31 Mar 21354,39122,78552,96312,501
31 Dec 20354,13324,89353,15912,619
30 Sep 20349,15221,85953,65512,619
30 Jun 20366,15221,87554,58812,619
31 Mar 20380,80322,70355,13112,619
31 Dec 19391,49923,32455,30211,986
30 Sep 19406,73324,50855,60211,986
30 Jun 19410,04323,83655,91711,986
31 Mar 19413,12825,04656,07411,986
31 Dec 18412,78322,51057,16911,477
30 Sep 18406,13422,15056,15211,477
30 Jun 18399,01023,22055,75111,477
31 Mar 18395,62923,03554,91711,477
31 Dec 17389,03723,53854,65811,102
30 Sep 17378,68424,30653,93911,102
30 Jun 17371,25121,95652,76711,102
31 Mar 17362,64718,14552,43711,102
31 Dec 16359,13417,16253,2579,656
30 Sep 16359,03215,70152,5009,656
30 Jun 16364,90817,33852,1869,656
31 Mar 16369,85319,47251,4989,656
31 Dec 15372,60121,03250,9758,796
30 Sep 15379,73521,38350,4338,796
30 Jun 15384,05121,36249,0708,796
31 Mar 15383,97819,02148,7538,796
31 Dec 14385,22415,99748,4058,699
30 Sep 14382,29213,64348,3378,699
30 Jun 14376,15411,50248,2168,699
31 Mar 14376,80913,57347,2098,699
31 Dec 13368,28713,78847,0408,330

Quality Earnings: 4061 has a large one-off gain of ¥5.3B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 4061's current net profit margins (2.2%) are higher than last year (1.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4061's earnings have declined by 19.7% per year over the past 5 years.

Accelerating Growth: 4061's earnings growth over the past year (75.2%) exceeds its 5-year average (-19.7% per year).

Earnings vs Industry: 4061 earnings growth over the past year (75.2%) exceeded the Chemicals industry 16.1%.

Return on Equity

High ROE: 4061's Return on Equity (2.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y